- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
Bill would require opioid CME for docs
A bill introduced recently by Sen. Jay Rockefeller would require physicians and other healthcare providers seeking to obtain or renew a U.S. Drug Enforcement Administration registration number to complete CME related to responsible opioid prescribing practices.
A bill introduced recently by Sen. Jay Rockefeller, (D-West Virginia) would require physicians and other healthcare providers seeking to obtain or renew a U.S. Drug Enforcement Administration registration number to complete CME related to responsible opioid prescribing practices.
In addition, the U.S. Food and Drug Administration (FDA) now is requiring manufacturers of long-acting and extended-release opioids to develop a risk evaluation and mitigation strategy, including educational materials for prescribers as well as materials for use when counseling patients.
The CME called for in the bill would be 16 hours of training every 3 years on treatment and management of opioid-dependent patients, pain management treatment guidelines, and early detection of opioid addiction.
